ASH – 2022 – Poster Presentation 4587
Publications
December 12, 2022
Efficient Multiplex Gene Editing of CD33 and CLL-1 in Human Hematopoietic Stem Cells Enables the Potential of Next-Generation Transplants for AML Treatment
Platform
Presented by: Juliana Xavier Ferrucio, PhD – Preclinical and Translational Biology – Vor Bio